Hhlr Advisors LTD. Buys 3,975 Shares of Danaher Co. (NYSE:DHR)

Hhlr Advisors LTD. boosted its position in shares of Danaher Co. (NYSE:DHRFree Report) by 43.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 13,079 shares of the conglomerate’s stock after purchasing an additional 3,975 shares during the quarter. Danaher comprises about 0.1% of Hhlr Advisors LTD.’s holdings, making the stock its 27th biggest holding. Hhlr Advisors LTD.’s holdings in Danaher were worth $3,002,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Howard Capital Management Group LLC raised its position in Danaher by 4.1% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after buying an additional 48 shares during the last quarter. Tudor Financial Inc. bought a new stake in shares of Danaher in the third quarter worth $414,000. Anchor Investment Management LLC increased its position in Danaher by 1.3% during the third quarter. Anchor Investment Management LLC now owns 6,039 shares of the conglomerate’s stock valued at $1,679,000 after acquiring an additional 78 shares during the last quarter. World Investment Advisors LLC boosted its position in Danaher by 5.3% in the third quarter. World Investment Advisors LLC now owns 12,948 shares of the conglomerate’s stock worth $3,600,000 after purchasing an additional 648 shares during the last quarter. Finally, Arvest Bank Trust Division bought a new stake in shares of Danaher during the 3rd quarter valued at about $254,000. 79.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.10% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages recently issued reports on DHR. JPMorgan Chase & Co. cut their target price on shares of Danaher from $280.00 to $260.00 and set an “overweight” rating for the company in a research report on Tuesday, April 22nd. Citigroup restated a “buy” rating on shares of Danaher in a research note on Monday, April 7th. The Goldman Sachs Group lowered their target price on Danaher from $260.00 to $240.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 23rd. Guggenheim restated a “buy” rating and issued a $250.00 price target on shares of Danaher in a research report on Wednesday, April 23rd. Finally, Jefferies Financial Group lowered their price objective on Danaher from $260.00 to $230.00 and set a “buy” rating on the stock in a research report on Tuesday, April 22nd. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $264.40.

Check Out Our Latest Stock Analysis on Danaher

Danaher Price Performance

Shares of NYSE:DHR opened at $196.01 on Tuesday. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a 50 day moving average of $200.69 and a 200 day moving average of $223.46. The stock has a market cap of $140.28 billion, a P/E ratio of 37.12, a P/E/G ratio of 2.66 and a beta of 0.86.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, sell-side analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 25th. Investors of record on Friday, March 28th were issued a dividend of $0.32 per share. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend was Friday, March 28th. Danaher’s dividend payout ratio is currently 24.85%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.